English
简体中文
Total: £ 56.28
Published Date: 2026-01-05 | Pages: 119 | Tables: 119 | Medical Devices & Consumables
The global Medical Non-Inactivated Virus Sampling Tubes market was valued at US$ 7.66 million in 2025 and is anticipated to reach US$ 12.42 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Non-Inactivated Virus Sampling Tubes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global sales of Medical Non-Inactivated Virus Sampling Tubes reached approximately 5.3 million units, with an average market price of about USD 1.3 per unit, an annual production capacity of roughly 7.5 million units, and an industry-average gross margin of approximately 26%.
A Medical Non-Inactivated Virus Sampling Tube is a laboratory consumable designed for collecting, transporting, and temporarily preserving live virus specimens (e.g., respiratory, enteric, or bloodborne viruses). These tubes typically consist of a transparent or semi-transparent plastic body, a secure cap, and a preservation medium that maintains viral integrity and infectivity for downstream molecular testing, viral isolation, culture, or research purposes. Key design considerations include leak-proof sealing, operator safety, transport convenience, and clear labeling. They are widely used in clinical diagnostics, public health surveillance, research laboratories, and emergency outbreak testing scenarios.
Upstream components include medical-grade plastics (PP, PS), caps and sealing gaskets, viral preservation medium ingredients (buffers, protein stabilizers, preservatives), and labeling/printing materials. Some manufacturers also require sterilization equipment or external sterilization services (gamma irradiation or ethylene oxide). Production is generally OEM-based, integrating tubes, caps, preservation medium, and labeling into a finished product. End users include hospitals, public health laboratories, third-party testing facilities, and research units. Non-inactivated virus sampling tubes are single-use consumables, discarded after sampling, transport, or testing. Consumption scales with sample volume; large public health labs or outbreak monitoring centers may use thousands to tens of thousands per day. Many laboratories pair these tubes with transport boxes, ice packs, and labeling systems to ensure sample safety and traceability.
The North American market for Medical Non-Inactivated Virus Sampling Tubes is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Medical Non-Inactivated Virus Sampling Tubes is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Medical Non-Inactivated Virus Sampling Tubes include Wondfo, Vazyme, Shanghai Bojie Medical, Beijing Baicare, Huachenyang, EKF, Youkang Biotechnology, Goldsite Diagnostics, VanGenes, MEDICO TECHNOLOGY, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Medical Non-Inactivated Virus Sampling Tubes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Non-Inactivated Virus Sampling Tubes. The Medical Non-Inactivated Virus Sampling Tubes market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Non-Inactivated Virus Sampling Tubes market comprehensively. Regional market sizes by Type, by Application, by Tube Volume, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Non-Inactivated Virus Sampling Tubes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Wondfo
Vazyme
Shanghai Bojie Medical
Beijing Baicare
Huachenyang
EKF
Youkang Biotechnology
Goldsite Diagnostics
VanGenes
MEDICO TECHNOLOGY
LAKEbio
Dewei Medical
YUGOMED
Segment by Type
PP
PS
Others
Segment by Tube Volume
1–3 mL
3–5 mL
Above 5 mL
by Application
Clinical
Public Health
Research Grade
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Tube Volume, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Non-Inactivated Virus Sampling Tubes manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Medical Non-Inactivated Virus Sampling Tubes sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Medical Non-Inactivated Virus Sampling Tubes Market Overview
1.1 Product Definition
1.2 Medical Non-Inactivated Virus Sampling Tubes by Type
1.2.1 Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Type: 2025 vs 2032
1.2.2 PP
1.2.3 PS
1.2.4 Others
1.3 Medical Non-Inactivated Virus Sampling Tubes by Tube Volume
1.3.1 Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Tube Volume: 2025 vs 2032
1.3.2 1–3 mL
1.3.3 3–5 mL
1.3.4 Above 5 mL
1.4 Medical Non-Inactivated Virus Sampling Tubes by Application
1.4.1 Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Application: 2025 vs 2032
1.4.2 Clinical
1.4.3 Public Health
1.4.4 Research Grade
1.4.5 Others
1.5 Global Medical Non-Inactivated Virus Sampling Tubes Market Size Estimates and Forecasts
1.5.1 Global Medical Non-Inactivated Virus Sampling Tubes Revenue 2021–2032
1.5.2 Global Medical Non-Inactivated Virus Sampling Tubes Sales 2021–2032
1.5.3 Global Medical Non-Inactivated Virus Sampling Tubes Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Medical Non-Inactivated Virus Sampling Tubes Market Competition by Manufacturers
2.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Non-Inactivated Virus Sampling Tubes Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Non-Inactivated Virus Sampling Tubes, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Product Types and Applications
2.7 Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Date of Entry into the Industry
2.8 Global Medical Non-Inactivated Virus Sampling Tubes Market Competitive Situation and Trends
2.8.1 Global Medical Non-Inactivated Virus Sampling Tubes Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Non-Inactivated Virus Sampling Tubes Players Market Share by Revenue
2.8.3 Global Medical Non-Inactivated Virus Sampling Tubes Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Non-Inactivated Virus Sampling Tubes Market Scenario by Region
3.1 Global Medical Non-Inactivated Virus Sampling Tubes Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Region: 2021–2032
3.2.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Region: 2021–2026
3.2.2 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Region: 2027–2032
3.3 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Region: 2021–2032
3.3.1 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Region: 2021–2026
3.3.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Region: 2027–2032
3.4 North America Medical Non-Inactivated Virus Sampling Tubes Market Facts & Figures by Country
3.4.1 North America Medical Non-Inactivated Virus Sampling Tubes Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (2021–2032)
3.4.3 North America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Non-Inactivated Virus Sampling Tubes Market Facts & Figures by Country
3.5.1 Europe Medical Non-Inactivated Virus Sampling Tubes Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Non-Inactivated Virus Sampling Tubes Sales by Country (2021–2032)
3.5.3 Europe Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Non-Inactivated Virus Sampling Tubes Market Facts & Figures by Country
3.7.1 Latin America Medical Non-Inactivated Virus Sampling Tubes Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (2021–2032)
3.7.3 Latin America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Type (2021–2032)
4.1.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Type (2021–2026)
4.1.2 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Type (2027–2032)
4.1.3 Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Type (2021–2032)
4.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Type (2021–2032)
4.2.1 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Type (2021–2026)
4.2.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Type (2027–2032)
4.2.3 Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Type (2021–2032)
4.3 Global Medical Non-Inactivated Virus Sampling Tubes Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Application (2021–2032)
5.1.1 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Application (2021–2026)
5.1.2 Global Medical Non-Inactivated Virus Sampling Tubes Sales by Application (2027–2032)
5.1.3 Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Application (2021–2032)
5.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Application (2021–2032)
5.2.1 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Application (2021–2026)
5.2.2 Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Application (2027–2032)
5.2.3 Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Application (2021–2032)
5.3 Global Medical Non-Inactivated Virus Sampling Tubes Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Wondfo
6.1.1 Wondfo Company Information
6.1.2 Wondfo Description and Business Overview
6.1.3 Wondfo Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Wondfo Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.1.5 Wondfo Recent Developments/Updates
6.2 Vazyme
6.2.1 Vazyme Company Information
6.2.2 Vazyme Description and Business Overview
6.2.3 Vazyme Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Vazyme Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.2.5 Vazyme Recent Developments/Updates
6.3 Shanghai Bojie Medical
6.3.1 Shanghai Bojie Medical Company Information
6.3.2 Shanghai Bojie Medical Description and Business Overview
6.3.3 Shanghai Bojie Medical Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shanghai Bojie Medical Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.3.5 Shanghai Bojie Medical Recent Developments/Updates
6.4 Beijing Baicare
6.4.1 Beijing Baicare Company Information
6.4.2 Beijing Baicare Description and Business Overview
6.4.3 Beijing Baicare Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Beijing Baicare Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.4.5 Beijing Baicare Recent Developments/Updates
6.5 Huachenyang
6.5.1 Huachenyang Company Information
6.5.2 Huachenyang Description and Business Overview
6.5.3 Huachenyang Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huachenyang Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.5.5 Huachenyang Recent Developments/Updates
6.6 EKF
6.6.1 EKF Company Information
6.6.2 EKF Description and Business Overview
6.6.3 EKF Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 EKF Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.6.5 EKF Recent Developments/Updates
6.7 Youkang Biotechnology
6.7.1 Youkang Biotechnology Company Information
6.7.2 Youkang Biotechnology Description and Business Overview
6.7.3 Youkang Biotechnology Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Youkang Biotechnology Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.7.5 Youkang Biotechnology Recent Developments/Updates
6.8 Goldsite Diagnostics
6.8.1 Goldsite Diagnostics Company Information
6.8.2 Goldsite Diagnostics Description and Business Overview
6.8.3 Goldsite Diagnostics Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Goldsite Diagnostics Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.8.5 Goldsite Diagnostics Recent Developments/Updates
6.9 VanGenes
6.9.1 VanGenes Company Information
6.9.2 VanGenes Description and Business Overview
6.9.3 VanGenes Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 VanGenes Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.9.5 VanGenes Recent Developments/Updates
6.10 MEDICO TECHNOLOGY
6.10.1 MEDICO TECHNOLOGY Company Information
6.10.2 MEDICO TECHNOLOGY Description and Business Overview
6.10.3 MEDICO TECHNOLOGY Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 MEDICO TECHNOLOGY Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.10.5 MEDICO TECHNOLOGY Recent Developments/Updates
6.11 LAKEbio
6.11.1 LAKEbio Company Information
6.11.2 LAKEbio Description and Business Overview
6.11.3 LAKEbio Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LAKEbio Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.11.5 LAKEbio Recent Developments/Updates
6.12 Dewei Medical
6.12.1 Dewei Medical Company Information
6.12.2 Dewei Medical Description and Business Overview
6.12.3 Dewei Medical Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Dewei Medical Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.12.5 Dewei Medical Recent Developments/Updates
6.13 YUGOMED
6.13.1 YUGOMED Company Information
6.13.2 YUGOMED Description and Business Overview
6.13.3 YUGOMED Medical Non-Inactivated Virus Sampling Tubes Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 YUGOMED Medical Non-Inactivated Virus Sampling Tubes Product Portfolio
6.13.5 YUGOMED Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Non-Inactivated Virus Sampling Tubes Industry Chain Analysis
7.2 Medical Non-Inactivated Virus Sampling Tubes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Non-Inactivated Virus Sampling Tubes Production Mode & Process Analysis
7.4 Medical Non-Inactivated Virus Sampling Tubes Sales and Marketing
7.4.1 Medical Non-Inactivated Virus Sampling Tubes Sales Channels
7.4.2 Medical Non-Inactivated Virus Sampling Tubes Distributors
7.5 Medical Non-Inactivated Virus Sampling Tubes Customer Analysis
8 Medical Non-Inactivated Virus Sampling Tubes Market Dynamics
8.1 Medical Non-Inactivated Virus Sampling Tubes Industry Trends
8.2 Medical Non-Inactivated Virus Sampling Tubes Market Drivers
8.3 Medical Non-Inactivated Virus Sampling Tubes Market Challenges
8.4 Medical Non-Inactivated Virus Sampling Tubes Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Tube Volume (US$ Million), 2025 vs 2032
Table 3. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global Medical Non-Inactivated Virus Sampling Tubes Market Competitive Situation by Manufacturers in 2025
Table 5. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units) of Key Manufacturers (2021–2026)
Table 6. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Manufacturers (2021–2026)
Table 7. Global Medical Non-Inactivated Virus Sampling Tubes Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market Medical Non-Inactivated Virus Sampling Tubes Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of Medical Non-Inactivated Virus Sampling Tubes, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Product Types and Applications
Table 13. Global Key Manufacturers of Medical Non-Inactivated Virus Sampling Tubes, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Medical Non-Inactivated Virus Sampling Tubes Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Non-Inactivated Virus Sampling Tubes Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Medical Non-Inactivated Virus Sampling Tubes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Medical Non-Inactivated Virus Sampling Tubes Sales by Region (K Units), 2021–2026
Table 19. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Region (2021–2026)
Table 20. Global Medical Non-Inactivated Virus Sampling Tubes Sales by Region (K Units), 2027–2032
Table 21. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Region (2027–2032)
Table 22. Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Region (US$ Million), 2021–2026
Table 23. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Region (2021–2026)
Table 24. Global Medical Non-Inactivated Virus Sampling Tubes Revenue by Region (US$ Million), 2027–2032
Table 25. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Region (2027–2032)
Table 26. North America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2021–2026
Table 28. North America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2027–2032
Table 29. North America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2021–2026
Table 30. North America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2027–2032
Table 31. Europe Medical Non-Inactivated Virus Sampling Tubes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2021–2026
Table 33. Europe Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2027–2032
Table 34. Europe Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2021–2026
Table 35. Europe Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Sales by Region (K Units), 2021–2026
Table 38. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Sales by Region (K Units), 2027–2032
Table 39. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2021–2026
Table 43. Latin America Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2027–2032
Table 44. Latin America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2021–2026
Table 48. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Sales by Country (K Units), 2027–2032
Table 49. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Revenue by Country (US$ Million), 2027–2032
Table 51. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units) by Type (2021–2026)
Table 52. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units) by Type (2027–2032)
Table 53. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Type (2021–2026)
Table 54. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Type (2027–2032)
Table 55. Global Medical Non-Inactivated Virus Sampling Tubes Revenue (US$ Million) by Type (2021–2026)
Table 56. Global Medical Non-Inactivated Virus Sampling Tubes Revenue (US$ Million) by Type (2027–2032)
Table 57. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Type (2021–2026)
Table 58. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Type (2027–2032)
Table 59. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Type (2021–2026)
Table 60. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Type (2027–2032)
Table 61. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units) by Application (2021–2026)
Table 62. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units) by Application (2027–2032)
Table 63. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Application (2021–2026)
Table 64. Global Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Application (2027–2032)
Table 65. Global Medical Non-Inactivated Virus Sampling Tubes Revenue (US$ Million) by Application (2021–2026)
Table 66. Global Medical Non-Inactivated Virus Sampling Tubes Revenue (US$ Million) by Application (2027–2032)
Table 67. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Application (2021–2026)
Table 68. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Application (2027–2032)
Table 69. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Application (2021–2026)
Table 70. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Application (2027–2032)
Table 71. Wondfo Company Information
Table 72. Wondfo Description and Business Overview
Table 73. Wondfo Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. Wondfo Medical Non-Inactivated Virus Sampling Tubes Product
Table 75. Wondfo Recent Developments/Updates
Table 76. Vazyme Company Information
Table 77. Vazyme Description and Business Overview
Table 78. Vazyme Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. Vazyme Medical Non-Inactivated Virus Sampling Tubes Product
Table 80. Vazyme Recent Developments/Updates
Table 81. Shanghai Bojie Medical Company Information
Table 82. Shanghai Bojie Medical Description and Business Overview
Table 83. Shanghai Bojie Medical Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. Shanghai Bojie Medical Medical Non-Inactivated Virus Sampling Tubes Product
Table 85. Shanghai Bojie Medical Recent Developments/Updates
Table 86. Beijing Baicare Company Information
Table 87. Beijing Baicare Description and Business Overview
Table 88. Beijing Baicare Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. Beijing Baicare Medical Non-Inactivated Virus Sampling Tubes Product
Table 90. Beijing Baicare Recent Developments/Updates
Table 91. Huachenyang Company Information
Table 92. Huachenyang Description and Business Overview
Table 93. Huachenyang Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. Huachenyang Medical Non-Inactivated Virus Sampling Tubes Product
Table 95. Huachenyang Recent Developments/Updates
Table 96. EKF Company Information
Table 97. EKF Description and Business Overview
Table 98. EKF Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. EKF Medical Non-Inactivated Virus Sampling Tubes Product
Table 100. EKF Recent Developments/Updates
Table 101. Youkang Biotechnology Company Information
Table 102. Youkang Biotechnology Description and Business Overview
Table 103. Youkang Biotechnology Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Youkang Biotechnology Medical Non-Inactivated Virus Sampling Tubes Product
Table 105. Youkang Biotechnology Recent Developments/Updates
Table 106. Goldsite Diagnostics Company Information
Table 107. Goldsite Diagnostics Description and Business Overview
Table 108. Goldsite Diagnostics Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Goldsite Diagnostics Medical Non-Inactivated Virus Sampling Tubes Product
Table 110. Goldsite Diagnostics Recent Developments/Updates
Table 111. VanGenes Company Information
Table 112. VanGenes Description and Business Overview
Table 113. VanGenes Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. VanGenes Medical Non-Inactivated Virus Sampling Tubes Product
Table 115. VanGenes Recent Developments/Updates
Table 116. MEDICO TECHNOLOGY Company Information
Table 117. MEDICO TECHNOLOGY Description and Business Overview
Table 118. MEDICO TECHNOLOGY Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. MEDICO TECHNOLOGY Medical Non-Inactivated Virus Sampling Tubes Product
Table 120. MEDICO TECHNOLOGY Recent Developments/Updates
Table 121. LAKEbio Company Information
Table 122. LAKEbio Description and Business Overview
Table 123. LAKEbio Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. LAKEbio Medical Non-Inactivated Virus Sampling Tubes Product
Table 125. LAKEbio Recent Developments/Updates
Table 126. Dewei Medical Company Information
Table 127. Dewei Medical Description and Business Overview
Table 128. Dewei Medical Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Dewei Medical Medical Non-Inactivated Virus Sampling Tubes Product
Table 130. Dewei Medical Recent Developments/Updates
Table 131. YUGOMED Company Information
Table 132. YUGOMED Description and Business Overview
Table 133. YUGOMED Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. YUGOMED Medical Non-Inactivated Virus Sampling Tubes Product
Table 135. YUGOMED Recent Developments/Updates
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Medical Non-Inactivated Virus Sampling Tubes Distributors List
Table 139. Medical Non-Inactivated Virus Sampling Tubes Customers List
Table 140. Medical Non-Inactivated Virus Sampling Tubes Market Trends
Table 141. Medical Non-Inactivated Virus Sampling Tubes Market Drivers
Table 142. Medical Non-Inactivated Virus Sampling Tubes Market Challenges
Table 143. Medical Non-Inactivated Virus Sampling Tubes Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Non-Inactivated Virus Sampling Tubes
Figure 2. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Medical Non-Inactivated Virus Sampling Tubes Market Share by Type: 2025 & 2032
Figure 4. PP Product Picture
Figure 5. PS Product Picture
Figure 6. Others Product Picture
Figure 7. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Tube Volume (US$ Million), 2021–2032
Figure 8. Global Medical Non-Inactivated Virus Sampling Tubes Market Share by Tube Volume: 2025 vs 2032
Figure 9. 1–3 mL Product Picture
Figure 10. 3–5 mL Product Picture
Figure 11. Above 5 mL Product Picture
Figure 12. Global Medical Non-Inactivated Virus Sampling Tubes Market Value by Application (US$ Million), 2021–2032
Figure 13. Global Medical Non-Inactivated Virus Sampling Tubes Market Share by Application: 2025 & 2032
Figure 14. Clinical
Figure 15. Public Health
Figure 16. Research Grade
Figure 17. Others
Figure 18. Global Medical Non-Inactivated Virus Sampling Tubes Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Medical Non-Inactivated Virus Sampling Tubes Market Size (US$ Million), 2021–2032
Figure 20. Global Medical Non-Inactivated Virus Sampling Tubes Sales (K Units), 2021–2032
Figure 21. Global Medical Non-Inactivated Virus Sampling Tubes Average Price (US$/Unit), 2021–2032
Figure 22. Medical Non-Inactivated Virus Sampling Tubes Report Years Considered
Figure 23. Medical Non-Inactivated Virus Sampling Tubes Sales Share by Manufacturers in 2025
Figure 24. Global Medical Non-Inactivated Virus Sampling Tubes Revenue Share by Manufacturers in 2025
Figure 25. Top 5 and Top 10 Global Medical Non-Inactivated Virus Sampling Tubes Players: Market Share by Revenue in Medical Non-Inactivated Virus Sampling Tubes in 2025
Figure 26. Medical Non-Inactivated Virus Sampling Tubes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 27. Global Medical Non-Inactivated Virus Sampling Tubes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 28. North America Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Country (2021–2032)
Figure 29. North America Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Country (2021–2032)
Figure 30. United States Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Canada Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Europe Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Country (2021–2032)
Figure 33. Europe Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Country (2021–2032)
Figure 34. Germany Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. France Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. U.K. Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Italy Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Russia Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Region (2021–2032)
Figure 40. Asia Pacific Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Region (2021–2032)
Figure 41. China Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Japan Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. South Korea Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. India Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Australia Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. China Taiwan Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Southeast Asia Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Country (2021–2032)
Figure 49. Latin America Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Country (2021–2032)
Figure 50. Mexico Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Colombia Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Sales Market Share by Country (2021–2032)
Figure 55. Middle East and Africa Medical Non-Inactivated Virus Sampling Tubes Revenue Market Share by Country (2021–2032)
Figure 56. Turkey Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Saudi Arabia Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. UAE Medical Non-Inactivated Virus Sampling Tubes Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Global Sales Market Share of Medical Non-Inactivated Virus Sampling Tubes by Type (2021–2032)
Figure 60. Global Revenue Market Share of Medical Non-Inactivated Virus Sampling Tubes by Type (2021–2032)
Figure 61. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Type (2021–2032)
Figure 62. Global Sales Market Share of Medical Non-Inactivated Virus Sampling Tubes by Application (2021–2032)
Figure 63. Global Revenue Market Share of Medical Non-Inactivated Virus Sampling Tubes by Application (2021–2032)
Figure 64. Global Medical Non-Inactivated Virus Sampling Tubes Price (US$/Unit) by Application (2021–2032)
Figure 65. Medical Non-Inactivated Virus Sampling Tubes Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
